Cargando…
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
BACKGROUND: Despite major advances in percutaneous coronary intervention (PCI), in-stent restenosis (ISR) remains a therapeutic challenge. We sought to compare the mid-term clinical outcomes after treatment with repeat drug-eluting stent (DES) implantation (“DES sandwich” technique) with DES placeme...
Autores principales: | Faramarzi, Negar, Salarifar, Mojtaba, Kassaian, Seyed Ebrahim, Zeinali, Ali Mohammad Haji, Alidoosti, Mohammad, Pourhoseini, Hamidreza, Nematipour, Ebrahim, Mousavi, Mohammad Reza, Goodarzynejad, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587669/ https://www.ncbi.nlm.nih.gov/pubmed/23646043 |
Ejemplares similares
-
Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010) -
One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016) -
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Poorhosseini, Hamid Reza, et al.
Publicado: (2012) -
One-Year Clinical Outcomes of Ultra Long Apollo Polymer-Based Paclitaxel-Eluting Stents in Patients with Complex, Long Coronary Artery Lesions
por: Salarifar, Mojtaba, et al.
Publicado: (2011) -
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)